A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome

NCT03189160 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Turner Syndrome

Interventions

BIOLOGICAL: PEG-rhGH low dose
BIOLOGICAL: PEG-rhGH high dose
OTHER: Non-treatment control group

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]